Need Help? Call 1­-866-­796-­7386
« back to stock screener

  MYGN stock: Myriad Genetics, Inc.

Current Rating
Hold/Sell

Previous Rating:

Buy
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$24.32
Market Cap
1.75B
Sector
Health Care
Div. Growth
-
P/E
42.2
P/B
2.35
P/S
2.32
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-1.8K
FCF
0.0
Op. Margin
9.00%
Net Margin
5.90%
ROE
6.00%
ROI
16.50%
ROA
3.80%
EPS Growth
-62.70%
Current Ratio
4.3
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Momenta Pharmaceuticals, Inc. (MNTA) $17.25 - - 1.27B Strong Buy
Perrigo Company PLC (PRGO) $75.51 - 0.80% 10.89B Strong Buy
STRATA Skin Sciences Inc (SSKN) $1.86 - - 5.8M Strong Buy
Birner Dental Mgmt Services In (BDMS) $12.75 - 6.50% 25.1M Strong Buy
Biostar Pharmaceuticals Inc (BSPM) $1.45 - - 4M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More